ホームBOIRF • OTCMKTS
add
Boiron SA
市場ニュース
財務情報
損益計算書
収益
純利益
| (EUR) | 2024年6月info | 前年比変化率 |
|---|---|---|
収益 | 1.14億 | -4.81% |
営業費用 | 7702.50万 | -4.80% |
純利益 | 166.60万 | -78.46% |
純利益率 | 1.46 | -77.36% |
1 株当たりの収益 | — | — |
EBITDA | 1136.90万 | -3.88% |
実効税率 | 25.19% | — |
貸借対照表
総資産
負債総額
| (EUR) | 2024年6月info | 前年比変化率 |
|---|---|---|
現金および短期投資 | 5332.60万 | -77.04% |
総資産 | 5.58億 | -25.92% |
負債総額 | 1.85億 | -8.91% |
純資産 | 3.73億 | — |
発行済み株式 | 1736.23万 | — |
帳簿価格 | 1.67 | — |
総資産利益率 | 3.06% | — |
資本利益率 | 4.40% | — |
キャッシュ フロー
現金の純増減額
| (EUR) | 2024年6月info | 前年比変化率 |
|---|---|---|
純利益 | 166.60万 | -78.46% |
営業キャッシュ フロー | 676.55万 | -17.50% |
投資キャッシュ フロー | -509.05万 | 24.82% |
財務キャッシュ フロー | -1322.65万 | -36.19% |
現金の純増減額 | -1135.55万 | -22.93% |
フリー キャッシュ フロー | 574.58万 | -7.44% |
概要
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it employed a workforce of 2,779 and had a turnover of € 313 million. It is currently a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "Proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
設立
1932/06/07
ウェブサイト
従業員数
2,788
